피나스테라이드: 프로페시아,핀페시아,프로스카,핀카등 전세계 피나스테리드계열 제네릭의약품 정보.

두타스테라이드: 아보다트, 제네릭아보다트 정보/ 미녹시딜정 : 먹는 미녹시딜 / 스피로놀락톤:알닥톤,스피로닥톤

미녹시딜 5%액 : 로게인,리게인, 잔드록스,마이녹실,스칼프메드등 minoxidil계열의 정보

기타의약품:시메티딘,로아큐탄,스티바A(트레티노인),다이안느, 드로겐정, 판토가

지난 주 댓글 랭킹

  • 1등 회원등급 국영수
  • 2등 회원등급 도와주새요
  • 3등 회원등급 hsw8688
  • 4등 회원등급 Awwxcfrf
  • 5등 회원등급 탈모는극복하는것
  • 6등 회원등급 기다림m
  • 7등 회원등급 fkwjmqke
  • 8등 회원등급 K4969242801
  • 9등 회원등급 K4970855537
  • 10등 회원등급 K4968883267

[두타스테리드] 젠장..글락소에서 두타의 탈모치료제로써의 3상 임상실험을 취소했답니다.

  • 23년 전

  • 1,591
0
November 11, 2002 - Hairlosshelp previously reported the news that Glaxo would be resuming Phase 3 hair loss trials. According to our sources they had already selected the sites for the studies and the trials were scheduled to begin in March 2003.

However late last week we received word that Glaxo has now called off the Phase 3 hair loss trials. This is now the second time that Glaxo has pulled the plug on its Phase 3 hair loss trials.

According to our source, the reason for this is that Glaxo's management does not think that Dutasteride will be able to be sufficiently differentiated from Propecia in the consumers mind to make the drug significantly profitable. We do not have any confirmation from Glaxo as to their reason why they pulled the plug.

Fortunately the U.S. Food and Drug Administration (FDA) has approved Dutasteride, also known as under its brand name Avodart®, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

This means that hair loss sufferers can still get this drug if its prescribed for off-label purposes by their physicians.

Dutasteride, a second-generation 5 alpha-reductase inhibitor, is the first and only medicine to inhibit both the type 1 and type 2 enzymes responsible for the conversion of testosterone to DHT (dihydrotestosterone), the primary cause of prostate growth. Dutasteride's dual inhibition decreases levels of DHT by 90 percent at two weeks and 93 percent at two years.

According to Glaxo, Dutasteride will be available in pharmacies in December 2002.

For more information about Dutasteride (Avodart®) visit www.dutasteride.org. />


SITE RESOURCES
Official Dutasteride Fact Sheet
Dutasteride Phase 2 Clinical Trial Results
New Dutasteride Study


OTHER RESOURCES (opens in new window)
Glaxo corporate web site
Merrill Lynch Global Pharmaceutical Investor Conference - September 25, 2001
Lehman Brothers - Dutasteride presentation - October 10, 2001
Bear Stearns HealthCare Conference - September 18, 2002




  • 본 게시물의 내용은 이용자의 개인적인 경험 및 공개된 일반 정보를 바탕으로 작성된 것으로, 특정 의약품의 광고, 홍보 또는 사용을 권유하기 위한 목적이 아닙니다. 전문의약품의 사용 여부 및 치료에 관한 사항은 반드시 의료 전문가와 상담하시기 바랍니다.

의약품 개인거래 게시물 신고하여 주시기 바랍니다. [포인트포상]

댓글

  • 최신순

    모발이식 포토&후기

    1 16

    우리동네 모발이식 병원지도

    병원지도